OpenIDEO is an open innovation platform. Join our global community to solve big challenges for social good. Sign up, Login or Learn more
I am passionate about:
Synthetic biology for social impact. Developing next generation solutions to solving some of our world's largest problems.
Show my name on the attendees list for events I am attending:
Calgary, AB, Canada
"Shoot for the moon. Even if you miss you'll land among the stars."
My passion is for learning, engineering, biology, and most importantly people. My technical background is in Biochemistry with a focus in Cancer Biology, and an in-formal training (>5 years) in Synthetic Biology managing projects as diverse as DNA assembly, bio-fuels, environmental remediation, and biosensors for toxins. My work within the innovation and education space has included developing science and entrepreneurial resources, DIY hacker spaces for biology, and commercializing products through startups.
Thanks for your interest. Happy to answer your questions: Regulatory Barriers - In North America, one of the only approved technologies allowed for compliance monitoring are found in analytical labs. This is because the existing field kits are often lacking in the accuracy and sensitivity required to sense toxic chemical compounds in water. We are looking to change this, and provide a new accurate means of generating water quality data. Phosphate Sensor - Presently, we have an arsenic sensor ready for pilot testing and our other sensors (including phosphate) are still in development. We are hoping to use the arsenic sensor as a means of validating our system and then expand our platform into various different type of chemical sensors. Patent - We actually just got word that our patent has been granted just a week ago! Very excited for this. Relocation - Our major challenge with relocation is that we have a synthetic biology that we created in Calgary, Canada and a staff of six that work full time on the technology development side. We often travel to Toronto and San Fransisco for business so consider ourselves fairly flexible on the business development side. The cost and difficulty in setting up the biotech infrastructure that we require makes it a bit of a challenge for our core team to relocate but would be interested in your perspective on this.